Transgender individuals' cancer survivorship: Results of a cross-sectional study

Ulrike Boehmer, Jessica Gereige, Michael Winter, Al Ozonoff, Nfn Scout, Ulrike Boehmer, Jessica Gereige, Michael Winter, Al Ozonoff, Nfn Scout

Abstract

Background: Transgender individuals' cancer prevalence and transgender cancer survivors' health needs have received scarce attention. The current study compared transgender and cisgender individuals' cancer prevalence and described the health needs of transgender cancer survivors.

Methods: The authors used Behavioral Risk Factor Surveillance System data on 95,800 cisgender and transgender individuals who self-reported a cancer diagnosis. Using multiple logistic regression, they estimated cancer prevalence and calculated odds ratios with 95% confidence intervals of physical, psychological, overall health, and health behaviors of transgender survivors compared with cisgender survivors.

Results: After adjusting for confounders, transgender men had a significantly higher (>2-fold) number of cancer diagnoses compared with cisgender men, but not cisgender women. Cancer prevalence among gender nonconforming individuals and transgender women was not significantly different from that of cisgender men and cisgender women. Gender nonconforming survivors had significantly greater physical inactivity, heavy episodic alcohol use, and depression compared with cisgender men and cisgender women. Transgender men survivors were significantly more likely to report poor physical health and greater medical comorbidities and were less likely to report smoking compared with cisgender men and cisgender women. Transgender women survivors were significantly more likely to report diabetes compared with cisgender men and cisgender women and were more likely to report cardiovascular disease compared with cisgender women.

Conclusions: Clinicians should be aware of the higher prevalence of cancer among transgender men and a potential survivorship bias among transgender individuals. Transgender survivors have considerable variation in their risk profile. Clinicians and health services can target gender nonconforming survivors' depression and health behaviors to improve survival and should address the complex comorbidities of transgender men and transgender women.

Keywords: cancer prevalence; cancer survivorship; comorbidities; disparities; gender minority; risk behaviors; transgender.

© 2020 American Cancer Society.

References

    1. Meyer IH, Brown TN, Herman JL, Reisner SL, Bockting WO. Demographic characteristics and health status of transgender adults in select US regions: Behavioral Risk Factor Surveillance System, 2014. Am J Public Health. 2017;107:582-589.
    1. Matsuno E, Budge SL. Non-binary/genderqueer identities: a critical review of the literature. Curr Sexual Health Rep. 2017;9:116-120.
    1. Griggs J, Maingi S, Blinder V, et al. American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations. J Clin Oncol. 2017;35:2203-2208.
    1. Braun H, Nash R, Tangpricha V, Brockman J, Ward K, Goodman M. Cancer in transgender people: evidence and methodological considerations. Epidemiol Rev. 2017;39:93-107.
    1. The Lancet Oncology. Cancer risk in the transgender community. Lancet Oncol. 2015;16:999.
    1. Becasen JS, Denard CL, Mullins MM, Higa DH, Sipe TA. Estimating the prevalence of HIV and sexual behaviors among the US transgender population: a systematic review and meta-analysis, 2006-2017. Am J Public Health. 2018:e1-e8.
    1. Halkitis PN, Valera P, LoSchiavo CE, et al. Human papillomavirus vaccination and infection in young sexual minority men: the P18 Cohort Study. AIDS Patient Care STDS. 2019;33:149-156.
    1. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609-e616.
    1. Buchting FO, Emory KT, Scout, et al. Transgender use of cigarettes, cigars, and e-cigarettes in a national study. Am J Prev Med. 2017;53:e1-e7.
    1. Jones BA, Haycraft E, Bouman WP, Arcelus J. The levels and predictors of physical activity engagement within the treatment-seeking transgender population: a matched control study. J Phys Act Health. 2018;15:99-107.
    1. Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68:31-54.
    1. Bazzi AR, Whorms DS, King DS, Potter J. Adherence to mammography screening guidelines among transgender persons and sexual minority women. Am J Public Health. 2015;105:2356-2358.
    1. Gibson AW, Radix AE, Maingi S, Patel S. Cancer care in lesbian, gay, bisexual, transgender and queer populations. Future Oncol. 2017;13:1333-1344.
    1. Clark M, Rosenthal S, Boehmer U. Cancer screening in lesbian and bisexual women and trans men. In: Boehmer U, Elk R, eds. Cancer and the LGBT Community: Unique Perspectives from Risk to Survivorship. Springer; 2015:83-98.
    1. Tabaac AR, Sutter ME, Wall CSJ, Baker KE. Gender identity disparities in cancer screening behaviors. Am J Prev Med. 2018;54:385-393.
    1. Hutchison LM, Boscoe FP, Feingold BJ. Cancers disproportionately affecting the New York State transgender population, 1979-2016. Am J Public Health. 2018;108:1260-1262.
    1. Nash R, Ward KC, Jemal A, Sandberg DE, Tangpricha V, Goodman M. Frequency and distribution of primary site among gender minority cancer patients: an analysis of U.S. national surveillance data. Cancer Epidemiol. 2018;54:1-6.
    1. Silverberg MJ, Nash R, Becerra-Culqui TA, et al. Cohort study of cancer risk among insured transgender people. Ann Epidemiol. 2017;27:499-501.
    1. Cathcart-Rake EJ. Cancer in sexual and gender minority patients: are we addressing their needs? Curr Oncol Rep. 2018;20:85.
    1. Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population; Board on Health Care Services; Institute of Medicine; Levit L, Balogh E, Nass S, et al, eds. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis. The National Academies Press; 2013.
    1. Alfano CM, Leach CR, Smith TG, et al. Equitably improving outcomes for cancer survivors and supporting caregivers: a blueprint for care delivery, research, education, and policy. CA Cancer J Clin. 2019;69:35-49.
    1. Downing JM, Przedworski JM. Health of transgender adults in the U.S., 2014-2016. Am J Prev Med. 2018;55:336-344.
    1. Schabath MB, Blackburn CA, Sutter ME, et al. National survey of oncologists at National Cancer Institute-designated comprehensive cancer centers: attitudes, knowledge, and practice behaviors about LGBTQ patients with cancer. J Clin Oncol. 2019;37:547-558.
    1. Siegel RL, Jemal A, Wender RC, Gansler T, Ma J, Brawley OW. An assessment of progress in cancer control. CA Cancer J Clin. 2018;68:329-339.
    1. Aizer AA, Chen MH, McCarthy EP, et al. Marital status and survival in patients with cancer. J Clin Oncol. 2013;31:3869-3876.
    1. Lee Smith J, Hall IJ. Advancing health equity in cancer survivorship: opportunities for public health. Am J Prev Med. 2015;49(6 suppl 5):S477-S482.
    1. Ward E, Halpern M, Schrag N, et al. Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin. 2008;58:9-31.
    1. Feldman J, Brown GR, Deutsch MB, et al. Priorities for transgender medical and healthcare research. Curr Opin Endocrinol Diabetes Obes. 2016;23:180-187.
    1. Fredriksen-Goldsen KI, Kim HJ, Barkan SE, Balsam KF, Mincer SL. Disparities in health-related quality of life: a comparison of lesbians and bisexual women. Am J Public Health. 2010;100:2255-2261.
    1. Afshar N, English DR, Thursfield V, et al. Differences in cancer survival by sex: a population-based study using cancer registry data. Cancer Causes Control. 2018;29:1059-1069.
    1. Cook MB, McGlynn KA, Devesa SS, Freedman ND, Anderson WF. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011;20:1629-1637.
    1. Dorak MT, Karpuzoglu E. Gender differences in cancer susceptibility: an inadequately addressed issue. Front Genet. 2012;3:268.
    1. American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2016-2017. American Cancer Society; 2016.
    1. Wolin K, Dart H, Colditz G. Eight ways to stay healthy after cancer: an evidence-based message. Cancer Causes Control. 2013;24:827-837.
    1. Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66:43-73.
    1. Spei ME, Samoli E, Bravi F, La Vecchia C, Bamia C, Benetou V. Physical activity in breast cancer survivors: a systematic review and meta-analysis on overall and breast cancer survival. Breast. 2019;44:144-152.
    1. Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies. Acta Oncol. 2015;54:635-654.
    1. Bonnet F, Irving K, Terra JL, Nony P, Berthezene F, Moulin P. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005;178:339-344.
    1. Tan C, Denlinger C. Cardiovascular toxicity in cancer survivors: current guidelines and future directions. American College of Cardiology [serial online] 2018. Accessed April 4, 2019.
    1. Shao S, Gill AA, Zahm SH, et al. Diabetes and overall survival among breast cancer patients in the U.S. military health system. Cancer Epidemiol Biomarkers Prev. 2018;27:50-57.
    1. Roy S, Vallepu S, Barrios C, Hunter K. Comparison of comorbid conditions between cancer survivors and age-matched patients without cancer. J Clin Med Res. 2018;10:911-919.
    1. Caceres BA, Jackman KB, Edmondson D, Bockting WO. Assessing gender identity differences in cardiovascular disease in US adults: an analysis of data from the 2014-2017 BRFSS. J Behav Med. Published online September 26, 2019. doi:10.1007/s10865-019-00102-8
    1. Getahun D, Nash R, Flanders WD, et al. Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study. Ann Intern Med. 2018;169:205-213.
    1. Alzahrani T, Nguyen T, Ryan A, et al. Cardiovascular disease risk factors and myocardial infarction in the transgender population. Circ Cardiovasc Qual Outcomes. 2019;12:e005597.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa